Category: Series
-
![Filament Health (FN.NEO) – Five Easy Questions with Maddy]()
Filament Health (FN.NEO) – Five Easy Questions with Maddy
Welcome to Five Easy Questions with Maddy Grace where we explain the public markets and the companies that trade on them. In today’s episode, Maddy speaks with Ben Lightburn, CEO of Filament Health, a new psychedelics company with a patented process for extracting compounds naturally and bottling them in consistent dose levels. Enjoy!
-
![Five Easy Questions with Maddy – Investing for Beginners]()
Five Easy Questions with Maddy – Investing for Beginners
This week Maddy speaks with investment guru and social media sensation, Matthew R. Nelson. Co-founder of Reflex Media, a public market awareness firm, and the power behind Matthew’s Millions, Matthew breaks down the key points in successful investment for beginners as well as seasoned investment vets. Enjoy!
-
![Equity.Guru starts a wrestling promotion]()
Equity.Guru starts a wrestling promotion
In this episode, Jody Vance catches up with Equity Guru’s founder and CEO Chris Parry to talk about the company’s latest updates and New Extreme Wrestling. Tune In!
-
![First glance with Jody Vance: Equity Guru CEO Chris Parry]()
First glance with Jody Vance: Equity Guru CEO Chris Parry
In this episode, Jody Vance catches up with Equity Guru’s founder and CEO Chris Parry to talk about the company’s latest updates and New Extreme Wrestling. Tune In!
-
![BetterLife Pharma (BETR.C) products show promise, but how’s their timing?]()
BetterLife Pharma (BETR.C) products show promise, but how’s their timing?
Drug science is all about timing. You can either take a preexisting molecule, which has benefits for alternative indications rather than what it’s originally on shelves for, and you after proving that it has these benefits during the regulatory dance, you take it to a new market, rebrand it and resell it. Easy. Or you…
-
![Analysis: BetterLife (BETR.C) implements a business-minded and cost-conscious approach to product research and development]()
Analysis: BetterLife (BETR.C) implements a business-minded and cost-conscious approach to product research and development
BetterLife is a biotechnology company that develops and commercializes psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and the European Union. Products Although the table below may seem complex is just a collection of the product names or titles and a description with the type of disease the product…
-
![To Invest or Not: BetterLife Pharma (BETR.C)]()
To Invest or Not: BetterLife Pharma (BETR.C)
In this episode, we look at BetterLife Sciences (BETR.C), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders. We check out their product pipeline and stock price to get a better idea of what the future may hold for potential investors.
-
![Analysis: Rockridge Resources (ROCK.V) ready to deploy excess cash]()
Analysis: Rockridge Resources (ROCK.V) ready to deploy excess cash
The Company is primarily a junior exploration company with no revenues from mineral-producing operations. They focus on copper and gold projects. The company’s flagship project is the Knife Lake Project, which consists of 81 claims totaling 55,471 hectares (137,069 acres) deposits located in Saskatchewan, Canada. It also owns 100% interest in the Raney gold project, which consists…
-
![An overlooked mining gem in an attractively priced industry]()
An overlooked mining gem in an attractively priced industry
Rockridge Resources (TSXV:ROCK) is a Canadian mining company located in Vancouver with 73 million shares outstanding and a market cap of $6.93M. Millions of mining companies share the same story, a Canadian gold company with hopes of one day becoming a large producer. As a mining investor, is it essential to look for projects where…
-
![Falcon Gold’s (FG.V) Canadian portfolio now covers Ontario, BC and red hot Newfoundland]()
Falcon Gold’s (FG.V) Canadian portfolio now covers Ontario, BC and red hot Newfoundland
Gold is currently trading around USD $1,750/ounce – down $70 in the last month and down $170 in the last 12 months. The current macro argument for high gold prices hinges on the accelerating degradation of fiat currency (paper), through money printing. The same argument was in vogue in ten years ago. Many pundits predicted…
